Labshake search

351 - 400 of 2505 citations for GOLM1 Human HEK 293 His since 2019

• Cancer-associated fibroblasts produce matrix-bound vesicles that influence endothelial cell function

  Alice Santi, et al., bioRxiv - Cancer Biology 2023

  Quote: ... and human TruStain FcXTM (1/200, BioLegend) for 45min on ice (100 μl/106 cells) ...
• Folate depletion induces erythroid differentiation through perturbation of de novo purine synthesis

  Adam G. Maynard, et al., bioRxiv - Molecular Biology 2022

  Quote: ... Transferrin receptor (human) (1:200; BioLegend, 334108).
• HIV-1 infection of genetically engineered iPSC-derived central nervous system-engrafted microglia in a humanized mouse model

  Alice K. Min, et al., bioRxiv - Neuroscience 2023

  Quote: ... CD45 (anti-human Alexa Fluor 700, Biolegend), CD206 (anti-human BV785 ...
• HIV-1 infection of genetically engineered iPSC-derived central nervous system-engrafted microglia in a humanized mouse model

  Alice K. Min, et al., bioRxiv - Neuroscience 2023

  Quote: ... and CD8 (anti-human PerCP-Cy5.5, Biolegend) for 30min at 4°C ...
• The CARD8 inflammasome drives CD4⁺ T-cell depletion in HIV-1 infection

  Qiankun Wang, Liang Shan, bioRxiv - Microbiology 2023

  Quote: ... anti-human CCR7-Alexa 647 (BioLegend #353218), anti-p24-PE (Beckman Coulter #KC57-RD1) ...
• Therapeutic Prime/Pull Vaccination of HSV-2 Infected Guinea Pigs with the Ribonucleotide Reductase 2 (RR2) Protein and CXCL11 Chemokine Boosts Antiviral Local Tissue-Resident and Effector Memory CD4⁺ and CD8⁺ T Cells and Protects Against Recurrent Genital Herpes

  Afshana Quadiri, et al., bioRxiv - Immunology 2023

  Quote: ... anti-mouse/human CD44 (clone IM7, Biolegend), anti-mouse CD69 (clone H1.2F3 ...
• Post-translational regulation of the Numb/Notch pathway in neurogenesis and cancer by Dlk2

  Stephanie.B Telerman, et al., bioRxiv - Cell Biology 2023

  Quote: ... Human B7-H2-Fc Chimera (Biolegend, 599904), Human SNAP43 (SNAPC1 ...
• Caspase-2 is essential for proliferation and self-renewal of nucleophosmin-mutated acute myeloid leukemia

  Dharaniya Sakthivel, et al., bioRxiv - Cancer Biology 2023

  Quote: ... APC anti-human CD14 (clone 63D3; BioLegend). Alexa Fluor 647 Phalloidin was purchased from Cell Signaling Technology ...
• Solid tumor-on-chip model for efficacy and safety assessment of CAR-T cell therapy

  Tengku Ibrahim Maulana, et al., bioRxiv - Bioengineering 2023

  Quote: ... anti-human CD4 APC/Fire750 (357426; BioLegend), anti-human CD8a PerCP (300922 ...
• Soluble CTLA-4 mainly produced by Treg cells inhibits type 1 inflammation without hindering type 2 immunity to allow for inflammation resolution

  Motonao Osaki, Shimon Sakaguchi, bioRxiv - Immunology 2023

  Quote: ... The anti-human IgG Fc Antibody (BioLegend) and the Sheep Anti-Rat IgG Dynabeads (Thermo Fisher Scientific ...
• Depletion of alloreactive B cells by chimeric alloantigen receptor T cells with drug resistance to prevent antibody-mediated rejection in solid organ transplantation

  Anna C. Dragon, et al., bioRxiv - Immunology 2023

  Quote: ... the LEGENDplex human CD8/NK Panel (BioLegend) was performed according to the manufacturer’s instructions ...
• Macrophage Migration Inhibitory Factor on Apoptotic Extracellular Vesicles Regulates Compensatory Proliferation

  Safia A. Essien, et al., bioRxiv - Cell Biology 2023

  Quote: ... The Human Anti-CD74 antibody (BioLegend, 326802) was stored at 4°C ...
• Vascularised Cardiac Spheroids-on-a-Chip for Testing the Toxicity of Therapeutics

  Stefania Di Cio, et al., bioRxiv - Bioengineering 2023

  Quote: ... APC anti- human CD140b (PDGFRβ, Biolegend 323608); Alexa Fluor 488 anti-fibronectin (eBioscience™) ...
• Therapeutic immune cell engineering with an mRNA : AAV-Sleeping Beauty composite system

  Lupeng Ye, et al., bioRxiv - Bioengineering 2023

  Quote: ... and 200U/mL human IL-2 (BioLegend).
• Therapeutic immune cell engineering with an mRNA : AAV-Sleeping Beauty composite system

  Lupeng Ye, et al., bioRxiv - Bioengineering 2023

  Quote: ... 20ng/mL of human GM-CSF (BioLegend) was used to differentiate monocytes into macrophages for 7 days ...
• Single-cell atlas of bronchoalveolar lavage from preschool cystic fibrosis reveals new cell phenotypes

  Jovana Maksimovic, et al., bioRxiv - Systems Biology 2022

  Quote: ... Human TruStain FcX FC blocking reagent (BioLegend) was added according to manufacturers’ instructions for 10min on ice ...
• Cancer-associated fibroblasts produce matrix-bound vesicles that influence endothelial cell function

  Alice Santi, et al., bioRxiv - Cancer Biology 2023

  Quote: ... and human TruStain FcXTM (1/200, BioLegend) in 100 μl of FACS buffer for 45min on ice ...
• Cancer-associated fibroblasts produce matrix-bound vesicles that influence endothelial cell function

  Alice Santi, et al., bioRxiv - Cancer Biology 2023

  Quote: ... and human TruStain FcXTM (1/200, BioLegend) in 100 μl of FACS buffer for 45min on ice ...
• T-cell derived extracellular vesicles prime macrophages for improved STING based cancer immunotherapy

  Aida S. Hansen, et al., bioRxiv - Immunology 2023

  Quote: ... or human IgG1 (clone MOPC-21) (Biolegend) for 30 min ...
• Engineered cytokine/antibody fusion proteins improve delivery of IL-2 to pro-inflammatory cells and promote antitumor activity

  Elissa K. Leonard, et al., bioRxiv - Bioengineering 2023

  Quote: ... BV605 anti-human CD8 (clone SK1, Biolegend); BV421 anti-human CD25 (clone M-A251 ...
• Co-engagement of TIGIT⁺ immune cells to PD-L1⁺ tumours by a bispecific antibody potentiates T-cell response and tumour control

  Xiaopei Cui, et al., bioRxiv - Immunology 2023

  Quote: ... APC/CY7 anti human CD16 (Biolegend/302017), FITC anti human CD107a antibodies (Biolegend/328606 ...
• Co-engagement of TIGIT⁺ immune cells to PD-L1⁺ tumours by a bispecific antibody potentiates T-cell response and tumour control

  Xiaopei Cui, et al., bioRxiv - Immunology 2023

  Quote: ... PE/CY7 anti-human TIGIT (Biolegend/372714). Binding of anti-TIGIT antibodies HB0036/HB0030 to cell surface was detected by APC-anti his (Biolegend/362605) ...
• Luminal epithelial cells integrate variable responses to aging into stereotypical changes that underlie breast cancer susceptibility

  Rosalyn W. Sayaman, et al., bioRxiv - Cancer Biology 2022

  Quote: ... or anti-human CD133-PE (BioLegend, clone7), and anti-human CD271-APC (BioLegend ...
• Therapeutic immune cell engineering with an mRNA : AAV-Sleeping Beauty composite system

  Lupeng Ye, et al., bioRxiv - Bioengineering 2023

  Quote: ... and 400U/mL human IL-2 (BioLegend). T cells were activated with Dynabeads Human T-Activator CD3/CD28 (ThermoFisher ...
• Carcinoma-associated fibroblast-like tumor cells remodel the Ewing sarcoma tumor microenvironment

  Emma D. Wrenn, et al., bioRxiv - Cancer Biology 2023

  Quote: ... 2.5 μL human TruStain FcX (BioLegend #42230) was added per sample and incubated at 4°C for 10 minutes ...
• Metabolic Reprogramming via targeting ACOD1 promotes polarization and anti-tumor activity of human CAR-iMACs in solid tumors

  Xudong Wang, et al., bioRxiv - Immunology 2023

  Quote: ... FITC Human IgG1 Isotype Control (403507, Biolegend), APC anti-human CD206 (321109 ...
• Gut microbiota and maternal immune transfer at birth influence pre-allergic clinical outcome

  Remy Villette, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human IgE PerCP-Cy5.5 (Biolegend, BLE325512) and human Fc biotin (009-060-008) ...
• Metabolic Reprogramming via targeting ACOD1 promotes polarization and anti-tumor activity of human CAR-iMACs in solid tumors

  Xudong Wang, et al., bioRxiv - Immunology 2023

  Quote: ... APC Human IgG1 Isotype Control (403505, Biolegend), FITC Human IgG1 Isotype Control (403507 ...
• Validation of ligand tetramers for the detection of antigen-specific lymphocytes

  Kristin S. Fitzpatrick, et al., bioRxiv - Immunology 2022

  Quote: ... anti-human HLA-ABC (W6/32, BioLegend), and anti-mouse H-2Kb (Y3 ...
• B-Cell Precursor Acute Lymphoblastic Leukemia elicits an Interferon-α/β response in Bone Marrow-derived Mesenchymal Stroma

  Mandy W. E. Smeets, et al., bioRxiv - Cancer Biology 2023

  Quote: ... PE anti-human CD4 and CD56 (Biolegend), Brilliant violet (BV)421 anti-human CD8 (Biolegend) ...
• The CARD8 inflammasome drives CD4⁺ T-cell depletion in HIV-1 infection

  Qiankun Wang, Liang Shan, bioRxiv - Microbiology 2023

  Quote: ... anti-human CD45-Pacific Blue (BioLegend # 304029), anti-human CD3-BV650 (BioLegend # 317324) ...
• Co-engagement of TIGIT⁺ immune cells to PD-L1⁺ tumours by a bispecific antibody potentiates T-cell response and tumour control

  Xiaopei Cui, et al., bioRxiv - Immunology 2023

  Quote: ... FITC anti human CD107a antibodies (Biolegend/328606) on ice for 30 min and then subjected to FACS analysis (BD/Canto II ...
• Designer small molecule control system based on Minocycline induced disruption of protein-protein interaction

  Ram Jha, et al., bioRxiv - Molecular Biology 2023

  Quote: ... APC anti-human EGFR antibody (Biolegend, 352905), Alexa Fluor® 488 anti-human EGFR antibody (Biolegend ...
• Selective Inhibition of Interleukin-2 Inducible T Cell Kinase (ITK) Enhances Anti-Tumor Immunity in Association with Th1-skewing, Cytotoxic T cell Activation, and Reduced T Cell Exhaustion

  Lih-Yun Hsu, et al., bioRxiv - Cancer Biology 2023

  Quote: ... and anti-human IL-12 (C8.6, Biolegend) neutralizing antibodies (10 mg/ml each ...
• Selective Inhibition of Interleukin-2 Inducible T Cell Kinase (ITK) Enhances Anti-Tumor Immunity in Association with Th1-skewing, Cytotoxic T cell Activation, and Reduced T Cell Exhaustion

  Lih-Yun Hsu, et al., bioRxiv - Cancer Biology 2023

  Quote: ... and anti-human IL-5 (TRFK5, Biolegend)neutralizing antibodies (10 ug/ml each ...
• Fine needle aspiration of human lymph nodes reveals cell populations and soluble interactors pivotal to immunological priming

  Nicholas M. Provine, et al., bioRxiv - Immunology 2023

  Quote: ... TotalSeq-C Human Universal Cocktail V1.0 (BioLegend) was prepared per manufacturer’s instructions and added to the cells without washing ...
• Solid tumor-on-chip model for efficacy and safety assessment of CAR-T cell therapy

  Tengku Ibrahim Maulana, et al., bioRxiv - Bioengineering 2023

  Quote: ... and anti-human CD25 BV421 (302630; BioLegend). Detailed information on the antibodies is summarized in Supplementary Table 2 ...
• Solid tumor-on-chip model for efficacy and safety assessment of CAR-T cell therapy

  Tengku Ibrahim Maulana, et al., bioRxiv - Bioengineering 2023

  Quote: ... anti-human CD3 PE/Cyanine7 (317334; BioLegend), anti-human CD4 APC/Fire750 (357426 ...
• Generation of circulating autoreactive pre-plasma cells fueled by naïve B cells in celiac disease

  Ida Lindeman, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human CD3-BV605 (clone UCHT1, BioLegend), anti-human CD14-BV510 (clone M5E2 ...
• Generation of circulating autoreactive pre-plasma cells fueled by naïve B cells in celiac disease

  Ida Lindeman, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human CD21-APC (clone Bu32, BioLegend), anti-human CD24-BV605 (clone ML5 ...
• Generation of circulating autoreactive pre-plasma cells fueled by naïve B cells in celiac disease

  Ida Lindeman, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human CD14-BV510 (clone M5E2, BioLegend), anti-human CD14-BV605 (clone M5E2 ...
• Engineered Immunogens to Elicit Antibodies Against Conserved Coronavirus Epitopes

  Brenda Kapingidza, et al., bioRxiv - Immunology 2023

  Quote: ... BV605 anti-human CD14 (clone M5E2, Biolegend), and BV711 anti-human IgM (clone G20-127 ...
• eQTL mapping in fetal-like pancreatic progenitor cells reveals early developmental insights into diabetes risk

  Jennifer P. Nguyen, et al., bioRxiv - Genomics 2023

  Quote: ... and SSEA-4 (PE anti-human, Biolegend) 35 ...
• Analysis of regulatory network modules in hundreds of human stem cell lines reveals complex epigenetic and genetic factors contribute to pluripotency state differences between subpopulations

  Timothy D. Arthur, et al., bioRxiv - Genomics 2023

  Quote: ... and SSEA-4 (PE anti-human, Biolegend). Pluripotency was also examined using PluriTest-RNAseq 70 ...
• Generation of circulating autoreactive pre-plasma cells fueled by naïve B cells in celiac disease

  Ida Lindeman, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human CD11c-BV605 (clone 3.9, Biolegend), anti-human CD19-Pacific blue (clone HIB19 ...
• Generation of circulating autoreactive pre-plasma cells fueled by naïve B cells in celiac disease

  Ida Lindeman, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human CD27-BV421 (clone O323, BioLegend), anti-human CD27-BV711 (clone M-T271 ...
• Generation of circulating autoreactive pre-plasma cells fueled by naïve B cells in celiac disease

  Ida Lindeman, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human CD14-BV605 (clone M5E2, BioLegend), anti-human CD11c-BUV805 (clone B-ly6 ...
• Generation of circulating autoreactive pre-plasma cells fueled by naïve B cells in celiac disease

  Ida Lindeman, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human CD38-BV605 (clone HIT2, BioLegend), anti-human CD38-FITC (clone HB7 ...
• Generation of circulating autoreactive pre-plasma cells fueled by naïve B cells in celiac disease

  Ida Lindeman, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human IgG-APC (clone M1310G05, BioLegend), anti-human IgM-BV510 (clone MHM-88 ...
• Generation of circulating autoreactive pre-plasma cells fueled by naïve B cells in celiac disease

  Ida Lindeman, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human CD3-BV510 (clone OKT3, BioLegend), anti-human CD3-BV605 (clone UCHT1 ...